SELLAS Life Sciences (SLS) Non-Current Assets (2010 - 2026)

SELLAS Life Sciences (SLS) has 17 years of Non-Current Assets data on file, last reported at $3.0 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 0.84% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $11.5 million, a 1.13% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, up 0.93% from the prior year.
• Non-Current Assets for Q1 2026 stood at $3.0 million, down from $3.1 million in the prior quarter.
• Over the last five years, Non-Current Assets for SLS reached as high as $3.6 million in Q1 2022 and fell as low as $2.5 million in Q3 2024.
• Historically, Non-Current Assets has averaged $3.0 million across 5 years, with a median of $3.0 million in 2026.
• Across the five-year window, Non-Current Assets sank 62.17% in 2022 and grew 1.9% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $3.2 million in 2022, then dropped by 4.39% to $3.0 million in 2023, then advanced by 1.9% to $3.1 million in 2024, then gained by 0.93% to $3.1 million in 2025, then fell by 4.02% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $3.0 million in Q1 2026, $3.1 million in Q4 2025, and $2.5 million in Q3 2025.